Company intelligence / Profile preview

Tuesday Capital

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Tuesday Capital is a seed-stage venture capital firm headquartered in San Francisco, California. Originally founded in 2011 as CrunchFund by Michael Arrington and Patrick Gallagher, the firm rebranded to Tuesday Capital in 2018 to emphasize its commitment to long-term founder relationships. The firm invests across a diverse array of sectors, including significant allocations toward healthcare, life sciences, and digital health startups. Tuesday Capital is known for being an early-stage partner, often participating in seed and Series A rounds for companies that leverage technology to solve complex problems. While not a drug developer itself, the firm's portfolio includes numerous innovative companies within the broader healthcare ecosystem.

Industry: Investors

Beyond the preview

Go deeper on Tuesday Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tuesday Capital.

Explore the full profile